Danaher Corporation (BVMF:DHER34)

Brazil flag Brazil · Delayed Price · Currency is BRL
43.24
-0.27 (-0.62%)
At close: Dec 4, 2025
-17.51%
Market Cap 865.00B
Revenue (ttm) 129.64B
Net Income (ttm) 18.71B
Shares Out n/a
EPS (ttm) 26.00
PE Ratio 46.22
Forward PE 27.75
Dividend 0.17 (0.39%)
Ex-Dividend Date Sep 25, 2025
Volume 12,307
Average Volume 6,747
Open 43.36
Previous Close 43.51
Day's Range 42.59 - 43.36
52-Week Range 33.66 - 53.36
Beta 0.93
RSI 56.59
Earnings Date Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man... [Read more]

Sector Healthcare
Founded 1969
Employees 63,000
Stock Exchange Brazil Stock Exchange
Ticker Symbol DHER34
Full Company Profile

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD Financial Statements

News

There is no news available yet.